跳至主要内容
临床试验/NCT01009229
NCT01009229已完成不适用

A Reduced 11 Beta Hydroxysteroid Dehydrogenase 2 (11 Beta HSD2) Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?

Insel Gruppe AG, University Hospital Bern2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Salt sensitivity, arterial hypertension

研究概览

简要总结

Consecutive living-kidney donor candidates (n=100) will be recruited after being accepted for donation according to official guidelines. An assessment of salt sensitivity, 11 beta HSD activity, 24 hour blood pressure, urine collection and physical exam will be performed prior nephrectomy and 14, 52, 156, 208 days post-nephrectomy.

详细描述

Consecutive living-kidney donor candidates (n=100) will be recruited after being accepted for donation. The assessment of salt sensitivity, 11 beta HSD activity, 24 hour blood pressure, urine collection and physical exam will be performed prior nephrectomy and 14, 52, 156, 208 days post-nephrectomy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • acceptance for living kidney donation

排除标准

  • withdrawal of consent

研究组 & 干预措施

1

Other

干预措施: Low and high salt diets (Dietary Supplement)

结局指标

主要结局

Salt sensitivity, arterial hypertension

时间窗: day 0, 14, 52, 156, 208, yearly

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验